Private equity deal activity has dropped by about 19% in the last 4 years—but healthcare-specific deals continue to grow at a steady rate year after year. That’s because healthcare organizations are a strong investment, with high margins and a product that will always be in demand, whether in biotechnology, medical devices, or private practice. However, […]